Fundamental Analysis
67 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +34.8% | +63.3% | 3 / 3 | +2.9% | -1.27 pp | +6.86 pp | +12.0% | 0.00 | 14.12 | 12,7 | +2,9% | 3,7 | +34,8% | 14.12 | 31.99 | −55,9% |
| Pts | 8 | 12 | 12 | 0 | 4 | 12 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 19.600 (close price on 2026-10-19)EPS (TTM): 1.389
Financial charts
1.Revenue & growth
VND bn12,7Q2/26
1.Revenue & growth
VND bn12,7Q2/26
2.Profit & growth
VND bn3,69Q2/26
3.Profit mix (Penman)
VND bn21,1Q2/26
4.Margins & cost structure
%46.2%Q2/26
5.Returns & cash cycle
% · days
6.Earnings quality & cash
VND bn24,2Q2/26
7.Asset structure
VND bn183Q2/26
8.Funding & debt health
VND bn · times183Q2/26
9.Revenue backlog
VND bn0,42Q2/26
10.Valuation
times · %14,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %298Q2/26
Adjusted EPS growth, latest quarter
34.7%
Average adjusted EPS growth, 3 quarters
63.3%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26